Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹1,365.60
Market cap: ₹16,766 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 27.8×Sector 50.4×
Promoter holding: 74.87%+0.00% QoQ
FII holding: 5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

16 Sep 2026 13:17 IST BSE

Merger & Restructuring

Alivus Life Sciences Merger & Restructuring Worth ₹0.9 Cr

Alivus Life Sciences incorporated a wholly owned pharma subsidiary in Brazil. The company subscribes up to R$500,000 (₹0.90 Cr) for 100% of the new entity.

Value: ₹0.90 Cr

Read the filing ↗

8 Sep 2026 20:11 IST BSE

Annual General Meeting

Alivus Life Sciences Annual General Meeting

Alivus Life Sciences Limited successfully conducted its 15th Annual General Meeting on September 8, 2026. All resolutions proposed in the AGM notice were passed with requisite majority.

Read the filing ↗